Zauderer Maurice's Form 4 filing
Vaccinex, Inc. (VCNX) · filed Oct 5, 2023
- Accession no.
- 0001062993-23-019063
- Filed
- Oct 5, 2023, 4:31 PM ET
- Trade date
- Oct 3-4, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market purchases total $509.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zauderer MauriceCIK 0001747753 | Director, Officer (President and CEO), 10% Owner |
| Vaccinex (Rochester), L.L.C.CIK 0001747866 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 3, 2023 | Common Stock | PPurchaseAcquired | +500,000 | $1.00 | +$500,000 | 979,599 | Indirect | |
| Oct 3, 2023 | Common Stock | PPurchaseAcquired | +5,000 | $0.93 | +$4,650 | 17,116 | Direct | |
| Oct 4, 2023 | Common Stock | PPurchaseAcquired | +5,000 | $0.973 | +$4,865 | 22,116 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 3, 2023 | Common Stock | PPurchaseAcquired | +500,000 | $1.00 | +$500,000 | 500,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.